Adnan Butt analyst

Currently out of the existing stock ratings of Adnan Butt, 52 are a BUY (86.67%), 3 are a HOLD (5%), 5 are a SELL (8.33%).

Adnan Butt

Work Performance Price Targets & Ratings Chart

Analyst Adnan Butt, has had 68.4% of price targets met with an average potential upside of 68.88%, reached in 522 days on average. Previously, Adnan Butt worked at GUGGENHEIM, RBC.

Adnan Butt has documented 134 price targets and ratings displayed on 14 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on REGN, Regeneron Pharmaceuticals at 22-Feb-2019.

Wall Street Analyst Adnan Butt

Analyst best performing recommendations are on NBRV (NABRIVA THERAPEUTICS AG).
The best stock recommendation documented was for NBRV (NABRIVA THERAPEUTICS AG) on 11/12/2015. The price target of $5500 was fulfilled within 35 days with a profit of $54000 (90.76%), with a performance score of 25.93.

Average potential price target upside

MDCO The Medicines Company MNKD MannKind Corp OCUL Ocular Therapeutix REGN Regeneron Pharmaceuticals SPPI Spectrum Pharmaceuticals AERI Aerie Pharmaceuticals ITCI Intracellular Th SGEN Seagen NBRV Nabriva Therapeutics AG XOMA XOMA Corp AVEO AVEO Pharmaceuticals GEMP Gemphire Therapeutics SCYX Scynexis NRBO Neurobo Pharmaceuticals

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 21-Mar-2016

$85

$90

6 years 11 months 25 days ago
(26-Nov-2019)

1/5 (20%)

$1.12 (1.34%)

1338

Buy Since 28-Mar-2019

$85

$100

6 years 11 months 26 days ago
(25-Nov-2019)

1/5 (20%)

$1.25 (1.49%)

243

Buy Since 30-Nov-2017

$68

$68

6 years 11 months 26 days ago
(25-Nov-2019)

4/6 (66.67%)

$-15.75 (-18.81%)

235

Hold Since 20-Nov-2019

$59

$55

7 years ago
(20-Nov-2019)

8/9 (88.89%)

$-11.59 (-16.42%)

148

Buy Since 19-Apr-2017

$60

$55

7 years 20 days ago
(31-Oct-2019)

5/5 (100%)

$7.51 (14.31%)

205

Show more analysts

Please expand the browser size to see the chart

✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?